Advertisment

Lupin Sunovion

Representative image
Drug maker Lupin on Thursday said it will acquire two inhalation brands from Sunovion Pharmaceuticals Inc for USD 75 million (around Rs 622 crore).The drug firm has inked a pact
Advertisment
Subscribe